3-(4-Fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide

Catalog No. :
ACROVK910
CAS No. :
1246818-88-1
Molecular Formula :
C26H24FNO3
Molecular Weight :
417.48

IUPAC Name:3-(4-fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide

3-(4-Fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide
IUPAC Name3-(4-fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide
MDL No.MFCD28143550
Molecular FormulaC26H24FNO3
Molecular Weight417.48
SMILESO=C(C1(CC(C)C)OC1(C(C2=CC=C(F)C=C2)=O)C3=CC=CC=C3)NC4=CC=CC=C4
InChI KeyWTTRRISNQAPVTN-UHFFFAOYSA-N
SynonymAtorvastatin Oxirane Impurity;3-(4-Fluorobenzoyl)-2-(2-Methylpropyl)-N,3-diphenyl-2-oxiranecarboxaMide;3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyloxirane-2-carboxylic Acid PhenylaMide;3-(4-fluorobenzoyl)-2-isobutyl-N,3-diphenyloxirane-2-carboxamide;Atorvastatin Impurity 77;2-Oxiranecarboxamide, 3-(4-fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyl-;Atorvastatin Impurity 174;3-(4-fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyloxirane-2-carboxamide
CAS No.1246818-88-1

Synthetic Route by SureRoute

1. ACROVK910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACROVK910 route product structure diagram
    ACROVK9101246818-88-1
Inquiry

2. ACROVK910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACROVK910 route product structure diagram
    ACROVK9101246818-88-1
Inquiry

Comments (0)